Research
- Research
- Biosimilars
- Drug Abuse Prevention
- Drug Adherence Programs
- Drug Cost Management
- Drug Coupons & Assistance Programs
- Drug Coverage Mandates
- Drug Price Negotiations & Rebates
- Employers, Unions, & Insurers
- FEHB Program
- Formulary Design
- Fraud, Waste, & Abuse
- Generic Drug Utilization
- Health Insurance Marketplace (ACA)
- Home Delivery of Drugs
- Medicaid
- Medicare Part D
- Patient Cost Sharing
- Pharmacy Networks
- Pharmacy Reimbursement & Contracting
- REMS Management
- Specialty Benefit Design
- Specialty Pharmacies
- Specialty Pharmacy Networks
- TRICARE
PCMA Member Survey: The Impact of POS Rebates and POS Pharmacy DIR
March 27, 2018
The Pharmaceutical Care Management Association (PCMA) had an independent third party conduct a survey of its members to assess the...
Milliman Analysis: Medicare Part D Program Characteristics that Affect Plan Sponsor Gain/Loss Margin
March 16, 2018
The Medicare Part D program has regulatory requirements and competitive dynamics that affect plan sponsor gain/(loss) margin. The Pharmaceutical Care...
Economic Impact of CMS’ Proposed Any Willing Pharmacy Policy
January 15, 2018
In its Notice of Proposed Rulemaking for 2019, the Centers for Medicare and Medicaid Services (CMS) has proposed what it...
